CRVO Earnings CervoMed Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q3 2024 | 2024-09-30 | -1.22 | 2024-11-12 | 10-Q |
| Q3 2024 | 2023-09-30 | -2.37 | 2024-11-12 | 10-Q |
| FY 2022 | 2022-12-31 | 2038891.00 | 2023-03-24 | 10-K |
| Q3 2023 | 2022-09-30 | -8.25 | 2023-11-13 | 10-Q |
| FY 2022 | 2021-12-31 | 1946859.00 | 2023-03-24 | 10-K |
| Q3 2021 | 2021-09-30 | 98810420.00 | 2021-11-10 | 10-Q |
| Q2 2021 | 2021-06-30 | 92713142.00 | 2021-08-11 | 10-Q |
| Q1 2021 | 2021-03-31 | 83420184.00 | 2021-05-07 | 10-Q |
| FY 2021 | 2020-12-31 | 53831973.00 | 2022-03-18 | 10-K |
| Q3 2021 | 2020-09-30 | 50216239.00 | 2021-11-10 | 10-Q |
| Q2 2021 | 2020-06-30 | 43242891.00 | 2021-08-11 | 10-Q |
| Q1 2021 | 2020-03-31 | 34507496.00 | 2021-05-07 | 10-Q |
| FY 2020 | 2019-12-31 | 6706509.00 | 2021-03-17 | 10-K |
| Q3 2020 | 2019-09-30 | 4005919.00 | 2020-11-12 | 10-Q |
| Q2 2020 | 2019-06-30 | 3658457.00 | 2020-08-07 | 10-Q |
| Q1 2020 | 2019-03-31 | 3376230.00 | 2020-05-11 | 10-Q |
| FY 2019 | 2018-12-31 | 3242301.00 | 2020-03-17 | 10-K |
| Q3 2019 | 2018-09-30 | 3185865.00 | 2019-11-08 | 10-Q |
| Q2 2019 | 2018-06-30 | 3092043.00 | 2019-08-08 | 10-Q |
| Q1 2019 | 2018-03-31 | 2814316.00 | 2019-05-09 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.